More articles from Movement Disorders

You have access
[¹⁸F]Florbetapir PET Imaging in Cognitively Normal Parkinson’s Disease
Yin Chen, Ilya Nasrallah, Rachel Goldmann Gross, Rizwan Akhtar, Howard Hurtig, Alice Chen-Plotkin, Lama Chahine, John Trojanowski, Daniel Weintraub and Jacob Dubroff

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 86;
You have access
Cardiac post-ganglionic sympathetic denervation correlates selectively with REM sleep behavior disorder symptoms in Parkinson disease.
Gulcin Altinok, Roger Albin, Ka Kit Wong, Martijn Muller, Vikas Kotagal, David Raffel, Ronald Chervin, Sid Gilman, Kirk Frey and Nicolaas Bohnen

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 81;
You have access
[¹⁸F]FP-CIT PET evidence that Pure Akinesia with Gait Freezing is a phenotypic spectrum of Progressive Supranuclear Palsy
Sangwon Han, In Joo Lee, Minyoung Oh, Jungsu Oh, Sang Ju Lee, Seung-Jun Oh, Sun Ju Chung, Hee Kyung Park and Jae Seung Kim

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 84;
You have access
Longitudinal assessment of PDE10 in Huntington disease (HD) using [¹⁸F]MNI-659 PET imaging.
David Russell, Danna Jennings, Olivier Barret, Gilles Tamagnan, Vincent Carroll, David Alagille, Thomas Morley, Caroline Papin, John Seibyl and Kenneth Marek

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 87;
You have access
Optimal acquisition time window for quantification of dopamine transporter availability with [¹⁸F]FE-PE2I in controls and PD patients
Ida Sonni, Patrik Fazio, Martin Schain, Christer Halldin, Per Svenningsson, Lars Farde and Andrea Varrone

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 85;
You have access
Influence of APOE ε4 genotype on α4β2* nicotinic acetylcholine receptor binding (α4β2*-nAChR) and cognitive dysfunction in Parkinson’s disease (PD): a 2-[18F]F-A-85380 (2-FA) PET study
Philipp Meyer, Georg Becker, Swen Hesse, Marianne Patt, Ralph Burkhardt, Henryk Barthel, Florian Wegner and Osama Sabri

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 82;
You have access
Associations between VMAT2 density and serum LDL, HDL levels in Parkinson's disease
Rui Gao, Guangjian Zhang, Xueqi Chen, Aimin Yang, Ming Zhang, Gwenn Smith, Dean Wong and Yun Zhou

Journal of Nuclear Medicine May 1, 2015, 56 (supplement 3) 83;
You have access
Cerebellar vermis vesicular acetylcholine transporter expression and parkinsonian motor impairment
Nicolaas Bohnen, Martijn Muller, Vikas Kotagal, Myria Petrou, Robert Koeppe, Peter Scott, Roger Albin and Kirk Frey

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 300;
You have access
Quantitative analysis of [¹⁸F]FE-PE2I binding to the dopamine transporter in Parkinson’s disease
Patrik Fazio, Per Svenningsson, Anton Forsberg, Erik Jönsson, Nahid Amini, Ryuji Nakao, Christer Halldin, Lars Farde and Andrea Varrone

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 303;
You have access
Development of neurodegenerative disease and dopamine transporter imaging in patients with idiopathic REM sleep behavior disorder: An 8-year follow-up
Hongyoon Choi, Young Eun Kim, Jong Min Kim, Byung Chul Lee and Sang Eun Kim

Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 302;

Main menu

User menu

Search

More articles from Movement Disorders

Pages